Metraipolis › archive › dc_b199d95c857d

Real-World Safety Profile of Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer — Europe PMC PMID:42649858

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42649858
DOI
10.3390/cancers18162543
License (as archived)
solo-consultazione
Archived
2026-10-16T23:53:17.171Z
SHA-256 of the archived text
473b24a32c474a66de743148a221bf0aa7cbbcb3e3dcd37a29109bfb11c40f37
Stable URL of this page
https://metraipolis.com/documento/dc_b199d95c857d

How to cite

Real-World Safety Profile of Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer — Europe PMC PMID:42649858 — Europe PMC (en), https://europepmc.org/article/MED/42649858 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b199d95c857d (Metraipolis archive dc_b199d95c857d, sha256 473b24a32c474a66de743148a221bf0aa7cbbcb3e3dcd37a29109bfb11c40f37)
BibTeX
@misc{dcb199d95c857d,
  title = {Real-World Safety Profile of Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer — Europe PMC PMID:42649858},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42649858},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b199d95c857d; sha256 473b24a32c474a66de743148a221bf0aa7cbbcb3e3dcd37a29109bfb11c40f37},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42649858. Agents can read the archived copy with the MCP tool read_document.